Trial record 1 of 3 for:    atomoxetine and Mild cognitive impairment
Previous Study | Return to List | Next Study

Effects of Atomoxetine in Mild Cognitive Impairment (ATX-001)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Emory University
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Allan I Levey, MD, Emory University
ClinicalTrials.gov Identifier:
NCT01522404
First received: January 25, 2012
Last updated: May 13, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2016
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)